MerLion Pharmaceuticals Pte Ltd

MerLion Pharmaceuticals Pte Ltd (MerLion) is a pharmaceutical company headquartered in Singapore, with clinical development operations based in Germany. The Company is focused on the discovery and development of innovative drug candidates aimed at addressing the increasing levels of bacterial and fungal resistance to existing therapies and thus, meet a growing medical need in both hospital and community settings.

The company also undertakes R&D activities with an outstanding portfolio of strategic partnerships containing many of the world's largest pharmaceutical and biotechnology companies. These partnerships reflect the industry-wide recognition that the rich diversity of chemistry found in natural products remains a vital source of new chemical entities.

MerLion has a novel, highly differentiated, drug candidate in phase 1 clinical development and a balanced preclinical portfolio derived from its innovative screening approaches, a unique patent position in the area of bacterial virulence and access to the proprietary discovery technologies of its partners.